Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
With a combined value of $14.1bn in 2019, there are ten high-growth medtech markets worth watching in Asia.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-eight guidance documents have been posted on the tracker since its last update.
Medtech consultant Arthur Brandwood explains why the EU’s medtech regulations are sending shockwaves through so many other countries, and why CE marking may be unlikely to return to its previous position as the preeminent international certification.
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-seven guidance documents have been posted on the tracker since its last update.
A new guidance document explains how Pakistan’s revamped therapeutic product surveillance system will work.
Requirements for advanced therapies in Hong Kong are being modeled on the EU regulatory regime.
Australia’s Therapeutic Goods Administration is pressing on with plans to move certain spinal implant devices from class IIb to the higher-risk class III.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.